TRDA - Entrada Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.00
DETAILS
HIGH:
$21.00
LOW:
$10.00
MEDIAN:
$20.00
CONSENSUS:
$17.00
UPSIDE:
159.15%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 83.9% |
| EBIT Margin | -561.8% |
| EBITDA Margin | -560.2% |
| Operating Margin | -613.7% |
| Pretax Margin | -561.8% |
| Cont. Ops Margin | -565.5% |
| Net Margin | -565.5% |
| Bottom Line Margin | -565.5% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 12.53 |
| Quick Ratio | 12.53 |
| Solvency Ratio | -2.012 |
| Cash Ratio | 3.70 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | 0.01 |
| Forward PEG | 0.01 |
| Price/Book | 1.39 |
| Price/Sales | 16.73 |
| Price/FCF | -3.28 |
| Price/Op Cash Flow | -3.31 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1350 |
| Debt/Equity | 0.1664 |
| Debt/Capital | 0.1426 |
| Long-Term Debt/Capital | 0.1326 |
| Financial Leverage | 1.23 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.07 |
| Operating Cash Flow Ratio | -5.256 |
| Operating Cash Flow/Sales | -505.5% |
| Free Cash Flow/Operating Cash Flow | 100.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -34.64 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -31.06 |
| Operating Cash Flow Coverage | -2.52 |
| Capital Expenditure Coverage | -123.45 |
| Dividend + Capital Expenditure Coverage | -123.45 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.61 |
| EPS | -3.475 |
| Debt/Share | 1.2311 |
| Cash/Share | 7.15 |
| Book Value/Share | 7.40 |
| Tangible BV/Share | 7.40 |
| Equity/Share | 7.40 |
| Operating Cash Flow/Share | -3.106 |
| Capital Expenditure/Share | 0.025 |
| FCF/Share | -3.131 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.006 |
| Earnings Before Tax/EBIT | 0.916 |
| Price/Fair Value | 1.39 |
| Debt/Market Cap | 0.1198 |
| Effective Tax Rate | -0.6% |
| Enterprise Value Multiple | -2.71 |